Page 123 - fbkCardioDiabetes_2017
P. 123

Cardio Diabetes Medicine 2017                                    99





                 itors, angiotensin  receptor blockers  (ARBs),  and   and peripheral resistance as well as by increased flu-
                 β-blockers.                                        id retention.

                 Although NSAIDs  have  an overall  modest effect on
                 blood pressure levels, in susceptible individuals sig-  Primary Aldosteronism
                 nificant  fluid retention,  increases  in blood  pressure,   Primary  aldosteronism  is  common  in  patients  with
                 and/or  acute  kidney  disease  may occur.  These  ef-  resistant hypertension with a prevalence of approxi-
                 fects  occur  secondary to inhibition  of renal prosta-  mately 20%, based on suppressed renin activity and
                 glandin production,  especially prostaglandin E2  and   a high 24-hour  urinary aldosterone excretion in the
                 prostaglandin I2, with  subsequent sodium and  fluid   course of a high dietary sodium intake.
                 retention. Elderly  patients, diabetics, and patients   Generalized activation  of the renin-angiotensin-al-
                 with CKD are at increased risk of manifesting these   dosterone  system  has been  described  with obesity,
                 adverse effects.
                                                                    while other studies suggest that adipocytes may re-
                 Other medications are sympathomimetic compounds    lease  secretagogues  that  stimulate  aldosterone  re-
                 such as decongestants and certain diet pills, amphet-  lease independent of angiotensin-II.
                 amine-like  stimulants, modafinil39, and oral  contra-
                 ceptives. Glucocorticoids, such as prednisone, induce  Pheochromocytoma
                 sodium and  fluid retention  and  can  result in signifi-  Pheochromocytoma represents a small but important
                 cant increases in blood pressure. Corticosteroids with   fraction of secondary  causes of resistant  hyperten-
                 the greatest  mineralocorticoid effect (eg, cortisone,   sion. The prevalence of pheochromocytoma is 0.1% to
                 hydrocortisone) produce the greatest amount of fluid   0.6% of hypertensives in a general ambulatory pop-
                 retention, but even agents without mineralocorticoid   ulation. The occurrence of a sustained increase and
                 activity  (eg, dexamethasone,  triamcinolone,  beta-  the degree of blood pressure variability are related to
                 methasone) produce  some  fluid  retention. Herbal   the level of norepinephrine secretion by the tumor.
                 preparations containing ephedra (or ma huang) have
                 been associated with worsening blood pressure. Lic-  Thediagnosis  of pheochromocytoma  should be  en-
                 orice, a common ingredient in oral tobacco products,   tertained in a hypertensive  patient  with  a combina-
                 can raise blood pressure by suppressing the metab-  tion of  headaches, palpitations,  and sweating,  typi-
                 olism  of cortisol, resulting  in increased stimulation   cally occurring in an episodic fashion.
                 of the mineralocorticoid receptor. In anemic patients   The  best  screening  test for  pheochromocytoma  is
                 with CKD, erythropoietic agents may increase blood   plasma  free  metanephrines (normetanephrine and
                 pressure in both normotensive and hypertensive pa-  metanephrine),  which  carries  a 99%  sensitivity and
                 tients.                                            an 89% specificity.

                 Secondary Causes                                   Cushing ’s syndrome
                 Secondary  causes  of hypertension  in patients with   Hypertension  is present  in 70%  to 90%  of patients
                 resistant hypertension, are older patients with great-  with Cushing’s syndrome. Although the main mech-
                 er  prevalence  of  sleep  apnea, renal  parenchymal   anism of hypertension in Cushing’s syndrome  is
                 disease,  renal  artery  stenosis,  and possibly  primary   overstimulation of the nonselective mineralocorticoid
                 aldosteronism.Others, include pheochromocytoma,    receptor by cortisol, other factors such as sleep ap-
                 Cushing’s  syndrome, hyperparathyroidism,  aortic   nea and the insulin resistance syndrome  are  major
                 coarctation, and intracranial tumors.              contributors to hypertension in this disease.

                 Obstructive Sleep Apnea                            Although the exact prevalence  of  resistant  hyper-
                                                                    tension in patients with Cushing’s syndrome  is  un-
                 There was a significant gender difference, with sleep   known, the overall CV risk in Cushing’s syndrome is
                 apnea being more common and more severe in the     substantial  because the disorder  is  associated with
                 men compared with women patients.                  other  major  risk  factors such as  diabetes  mellitus,
                 A  well-described  effect is  that  the intermittent  hy-  the metabolic syndrome,  sleep  apnea, obesity,  and
                 poxemia,  and/or  increased  upper  airway  resistance   dyslipidemia, in addition to hypertension.
                 associated with sleep apnea, induces a sustained in-  Surgical excision of an adrenocorticotropic hormone
                 crease in sympathetic nervous system (SNS) activity.   (ACTH) or cortisol-producing tumor effectively lowers
                 Increases in SNS output would be expected to raise   blood  pressure.  The  most effective  antihypertensive
                 blood  pressure  through increases  in cardiac output   pharmacological agent in  Cushing’s syndrome  is  a


                                                    Cardio Diabetes Medicine
   118   119   120   121   122   123   124   125   126   127   128